Immobilization of<i>Candida rugosa</i>lipase by adsorption-crosslinking onto corn husk

Nuraliyah, Andi; Wijanarko, Anondho; Hermansyah, Heri

doi:10.1088/1757-899x/345/1/012042

Cited by 7 publications

(1 citation statement)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…These materials usually have a high surface area and various functional groups (hydroxyl-, carboxyl-, amino-, thiol-, and others) available for immobilization [ 19 , 21 ]. Examples of successfully used supporters from this group are eggshell [ 21 , 22 ], eggshell membrane [ 21 , 23 , 24 , 25 ], coconut fiber [ 21 , 26 , 27 , 28 ], corn cob [ 21 , 29 ], corn husk [ 21 , 30 ], rice husk [ 21 , 27 , 31 , 32 ], spent coffee grounds [ 21 , 33 , 34 ], spent grains [ 21 , 35 ], and so on.…”

Section: Principles Of Green Chemistry—a New Approach To the Synthesi...mentioning

confidence: 99%

Research in the Field of Drug Design and Development

Biala,

Kedzierska,

Kruk-Slomka

et al. 2023

Pharmaceuticals

View full text Add to dashboard Cite

The processes used by academic and industrial scientists to discover new drugs have recently experienced a true renaissance, with many new and exciting techniques being developed over the past 5–10 years alone. Drug design and discovery, and the search for new safe and well-tolerated compounds, as well as the ineffectiveness of existing therapies, and society’s insufficient knowledge concerning the prophylactics and pharmacotherapy of the most common diseases today, comprise a serious challenge. This can influence not only the quality of human life, but also the health of whole societies, which became evident during the COVID-19 pandemic. In general, the process of drug development consists of three main stages: drug discovery, preclinical development using cell-based and animal models/tests, clinical trials on humans and, finally, forward moving toward the step of obtaining regulatory approval, in order to market the potential drug. In this review, we will attempt to outline the first three most important consecutive phases in drug design and development, based on the experience of three cooperating and complementary academic centers of the Visegrád group; i.e., Medical University of Lublin, Poland, Masaryk University of Brno, Czech Republic, and Comenius University Bratislava, Slovak Republic.

show abstract